The shift comes after a federal court struck down sweeping changes to the pediatric vaccine schedule that went into effect in 2026. The committee of medical experts, which advises on policy at the Centers for Disease Control and Prevention (CDC), will have to focus on a cost-benefit analysis in its future analyses.